| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 151.66 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Polypharmacy is associated with drug–drug interactions, adverse drug events, hospitalization, increased mortality and rising costs. Older cancer patients are potentially vulnerable to polypharmacy because cancer treatment often involves exposure to chemotherapy and other adjunctive or supportive medication.
Descrição
Palavras-chave
Elderly patients Older patients Polypharmacy Cancer Chemotherapy
Contexto Educativo
Citação
Oliveira, R., Afreixo, V., Santos, J., Mota, P., Cruz, A., & Pimentel, F. (2016). Polypharmacy in older patients with cancer. Proceedings of the 3rd IPLeiria’s International Health Congress - BMC Health Services Research, 16 (3), 86.